Clinical Trials Logo

Clinical Trial Summary

This study is designed to explore lung function effects of two doses of indacaterol acetate, 75 μg and 150 μg, in pediatric asthma patients 6-11 years old, and to compare the systemic exposure to indacaterol in plasma with historical data in adults, to identify an appropriate dose to Phase III evaluation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02892019
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone +41613241111
Email novartis.email@novartis.com
Status Recruiting
Phase Phase 2
Start date April 18, 2017
Completion date April 17, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03086460 - A Dose Ranging Study of CHF 1531 in Asthmatic Subjects Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Recruiting NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Active, not recruiting NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Completed NCT01318980 - A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A Phase 1
Recruiting NCT02782065 - Validation of the Hospital Asthma Severity Score (HASS)
Withdrawn NCT02546869 - A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting Phase 3
Completed NCT02449473 - Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids Phase 2
Completed NCT01691859 - MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects Phase 3
Completed NCT01687283 - Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma Phase 3
Completed NCT00446056 - Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) Phase 4
Completed NCT00972673 - A Study of GW685698X in Healthy Japanese Male Subjects Phase 1
Withdrawn NCT02794519 - A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma Phase 2
Completed NCT02501629 - An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils Phase 3
Completed NCT03273127 - To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids Phase 1
Not yet recruiting NCT03365687 - Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers Phase 3